Unlocking New Frontiers in Rheumatoid Arthritis: The Therapeutic Promise of Obakulactone
Rheumatoid arthritis (RA)—a debilitating autoimmune condition that affects roughly 1% of the global population—has long presented a formidable challenge to modern medicine. Characterized by the immune system’s misguided assault on synovial tissues, RA…